Saturday 17 October 2026 Export TGTX’s income statement to Excel — free account

TG Therapeutics, Inc.

TG Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $616.3 million, up 87.3% from fiscal 2024. In the quarter to June 2026, revenue grew 70.3%, EPS fell 73.7%, free cash flow grew 427.1% and total debt rose 204.2%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

53.97 2.03 −3.63%

Follow TGTX

Alert me

Market cap: $8.6B
P/E: 17.8×
Fwd P/E: 29.4×
Dividend yield: —
F-score: 5/9
Altman Z: 6.29
Beneish M: 0.80
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	11.77	9.71	10.45	18.07
P/S ratio Full definition →		9.88	6.98	6.85	9.74
P/FCF ratio Full definition →		0.00	0.00	0.00	448.02
P/Operating CF Full definition →		(226.92)	218.82	(268.15)	198.38
P/B ratio Full definition →		8.65	6.64	8.23	12.89
Price to Tangible BV Full definition →		8.66	6.65	8.24	12.91
EV/Sales Full definition →		10.09	7.15	7.18	9.98
EV/EBITDA Full definition →		54.16	36.42	33.95	58.71
EV/Operating CF Full definition →		(76.62)	(177.89)	(360.54)	446.57
EV/FCF Full definition →		(76.43)	(176.37)	(354.45)	459.19
Quick Ratio Full definition →		2.53	2.91	4.84	3.55
Current Ratio Full definition →		3.82	4.10	5.81	4.27
Net Debt/EBITDA Full definition →		3.93	2.05	6.63	8.87
Debt/Assets Full definition →		23.94%	23.10%	48.74%	45.46%
Debt/Equity Full definition →		0.40	0.38	1.28	1.23
Asset Turnover Full definition →		0.66	0.75	0.64	0.68
Operating CF/Net income Full definition →		(0.06)	0.85	(0.90)	5.05
Capex/Depreciation Full definition →		0.19	5.58	25.50	(3.29)
Interest Coverage Full definition →		4.37	7.73	4.54	1.31
Research and Development Expense of Revenue Full definition →		25.28%	23.12%	21.24%	39.67%
Selling, General and Administrative Expense of Revenue Full definition →		39.19%	30.85%	45.43%	34.17%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		10.94%	8.13%	9.74%	11.60%
Graham Net Nets Full definition →		0.03	0.05	0.03	0.01
Graham Number Full definition →		16.98	17.61	17.00	17.07
Earnings Yield Full definition →		8.50%	10.30%	9.57%	5.53%
Free Cash Flow Yield Full definition →		(1.34%)	(0.58%)	(0.30%)	0.22%
Revenue per Share Full definition →		1.11	1.33	1.42	1.70
Operating CF per Share Full definition →		(0.16)	0.14	(0.12)	0.28
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(0.16)	0.14	(0.12)	0.27
Cash per Share Full definition →		0.90	0.98	3.56	3.90
Shareholders Equity per Share Full definition →		4.18	4.49	4.04	4.26
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		4.18	4.49	4.04	4.26
Free Cash Flow Full definition →		(23.23)	19.59	(17.94)	38.97
Working Capital Full definition →		442.96	477.00	899.86	877.19
Capital Expenditures Full definition →		(0.08)	(0.07)	(0.05)	(0.29)
Net Current Asset Value Full definition →		181.96	215.53	141.26	110.14
EV/EBIT Full definition →		52.23	35.73	33.65	58.56
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Price to Operating Income Full definition →		51.12	34.88	32.10	57.13
Other line items
Average Receivables Full definition →		190.56	217.41	291.08	316.54
Average Payables Full definition →		106.87	82.90	141.39	173.86
Average Inventory Full definition →		115.81	118.02	143.39	151.59
Average Assets Full definition →		805.52	820.47	1,092.76	1,171.12
Average Common Equity Full definition →		399.69	435.19	410.21	440.26

Show all line items

Columns are period end dates

Stockrow Weekly